Summary: Stryker announced an agreement to acquire Vertos Medical Inc., a company specializing in minimally invasive treatments for lumbar spinal stenosis, to enhance its pain management portfolio.
Key Takeaways:
- Stryker’s acquisition of Vertos Medical will strengthen its minimally invasive pain management offerings.
- Vertos Medical’s mild procedure offers pain relief and improved mobility for patients with lumbar spinal stenosis.
Stryker announced a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.
Impact of Lumbar Spinal Stenosis
Lumbar spinal stenosis affects millions of people globally and is a leading cause of pain and disability. Minimally invasive treatment options are designed to reduce recovery times and help patients return to daily life. Vertos Medical’s mild procedure offers a solution for pain relief and may improve mobility without the need for major surgery, according to the company.
“We are committed to helping customers restore patients’ quality of life with interventional solutions to address chronic pain,” said Andy Pierce, group president, MedSurg and Neurotechnology, Stryker. “This acquisition strengthens our minimally invasive pain management portfolio with differentiated treatments and expands our reach across ambulatory surgery centers.”
Pending Transaction Closure
The transaction is subject to customary closing conditions. Stryker and Vertos Medical Inc. will continue to operate as separate entities and proceed as usual until the transaction closes.
“Allowing patients to get back to what matters most to them is what matters most to us,” says Eric Wichems, Vertos Medical’s CEO. “Stryker’s mission and focus on interventional solutions provides an opportunity to further improve patients’ quality of life.”
